ClinicalTrials.govpublic full text
A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
erosive esophagitis, lansoprazole, los angeles grade, double-blind, active comparator-controlled, proton-pump inhibitor, dose selection, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 859954
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.